A recent study conducted at the Oncology Department of Miguel Servet University Hospital in Zaragoza, Spain, highlights the significant mental health challenges faced by hospitalized cancer patients. Researchers found that nearly half of cancer patients admitted to the hospital experience clinically significant anxiety, and over 40% exhibit symptoms of depression, with these issues persisting even during the discharge process. The findings, reported in the journal Supportive Care in Cancer, provide a detailed look at the psychological states of cancer inpatients upon admission and discharge.

Read More

Led by Paula Morillas-Martínez, the study involved 166 hospitalized cancer patients. Utilizing validated psychometric tools, the researchers assessed emotional distress using the Hospital Anxiety and Depression Scale (HADS) and additional questionnaires to gauge social support and patient-clinician interactions. The results revealed that 47% of patients screened positive for anxiety at admission, and 43% for depression. By the time of discharge, these numbers had only improved slightly, with 40% of patients still anxious and 39% still depressed.

The study further analyzed factors contributing to mental health outcomes. It found that pre-existing psychiatric vulnerabilities significantly impacted anxiety, with 29.5% of anxious patients on anxiolytics before admission compared to 13.6% of non-anxious patients. Antidepressant use also correlated closely, with 25.6% of anxious patients on these medications versus 11.4% of others.

Contrastingly, depression was more related to the severity of physical illness. Patients with an Eastern Cooperative Oncology Group performance status of two or higher—indicating substantial assistance needs—showed a depression rate of 64.7%, compared to 42.1% for those with better functional status. Additionally, opioid use was associated with higher depression rates, affecting 62% of depressed patients.

At discharge, the quality of care experienced by patients was influential. Those who reported poorer relationships with their oncologists were more likely to be anxious at discharge, with 26.7% of patients experiencing anxiety compared to 12.1% of those with better relationships. Moreover, lower levels of perceived social support correlated with increased anxiety and depression.

Physical symptoms such as fatigue were also significant factors. Fatigue at discharge was associated with higher anxiety, affecting 36.7% of fatigued patients, while 35.6% of fatigued patients also reported increased depression. Such findings suggest that symptom management and improved communication strategies within healthcare settings could help alleviate psychological distress.

The study's design has its limitations, being observational and conducted at a single center. It cannot definitively conclude causation but indicates a clear association between psychological distress and various clinical factors. Given that around 40% of patients remain psychologically distressed upon leaving the hospital, the authors emphasize the need for routine mental health assessments and interventions to address these issues effectively.

Overall, the research underscores the importance of integrating mental health care in oncology settings as a means to better support patients during their cancer treatment journeys.